Reaffirmed Guidance Amid Losses and New Defense LiDAR Deals Could Be A Game Changer For Innoviz Technologies (INVZ)

In May 2026, Innoviz Technologies reported Q1 2026 revenue of US$7.13 million and a net loss of US$26.2 million, while reiterating full-year revenue guidance of US$67 million to US$73 million despite weaker near-term results. At the same time, Innoviz announced new agreements spanning defense LiDAR deployments, on-sensor perception software evaluation, and LOXO’s autonomous delivery platform, signaling broader applications beyond passenger vehicles. Next, we’ll examine how reaffirmed revenue guidance amid a sharp year-over-year sales decline could reshape Innoviz’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 42 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Innoviz Technologies Investment Narrative Recap

To own Innoviz, you need to believe that its LiDAR and perception software can convert development wins into durable, higher margin production revenue across automotive and nonautomotive uses. Right now, the key near term catalyst is execution on 2026 revenue guidance despite Q1’s sharp drop, while the biggest risk is ongoing cash burn and dependence on milestone based NRE and future production ramps. The latest results make that execution risk feel more immediate, but do not fully redefine the story.

Among the recent announcements, the framework agreement with Kela Technologies stands out here, because it directly supports Innoviz’s push into defense and homeland security just as automotive program timing remains uncertain. While the initial quantities are limited to several hundred InnovizTwo units, the agreement illustrates how nonautomotive wins could partially offset NRE lumpiness and customer concentration in passenger vehicles if they translate into repeat or scaled orders over time.

Yet despite this potential, investors should be aware that liquidity and dilution risk remain front and center if revenue progress stalls and...

Read the full narrative on Innoviz Technologies (it's free!)

Innoviz Technologies’ narrative projects $197.6 million in revenue and $15.7 million in earnings by 2029.

Uncover how Innoviz Technologies' forecasts yield a $2.02 fair value, a 175% upside to its current price.

Exploring Other PerspectivesINVZ 1-Year Stock Price Chart

Before this miss, the most bearish analysts were already assuming about US$117.6 million of revenue by 2028 and no profits, highlighting how much more cautious they are on cash burn and contract conversion than the baseline view.

Explore 5 other fair value estimates on Innoviz Technologies - why the stock might be worth over 5x more than the current price!

Story Continues

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

A great starting point for your Innoviz Technologies research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision. Our free Innoviz Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Innoviz Technologies' overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

Uncover the next big thing with 25 elite penny stocks that balance risk and reward. Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution. AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include INVZ.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments